NurExone Reports Q1FY23 Financial Results and Provides Corporate Update
NurExone Reports Q1FY23 Financial Results and Provides Corporate Update
May 24, 2023
NurExone Reports Q1FY23 Financial Results and Provides Corporate Update
Annual General Meeting [AGM] planned to June 28 2023
NurExone Q4FY22 Annual Management’s Discussion and Analysis
2022 NurExone Business Plan – Executive Summary [will be uploaded soon]
Name Change Alberta Corporation post RTO to NurExone Biologic Inc
NurExone Certificate of Amendment – Government of Alberta – Corporate #2016152585
NurExone Q1FY23 Management’s Discussion and Analysis
NurExone Q1FY23 Interim Financial Statements